List of bibliographic references
Number of relevant bibliographic references: 37.
[20-40] [
0 - 20][
0 - 37]
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 26 | Humans |
| 20 | Male |
| 15 | Female |
| 15 | Middle Aged |
| 15 | Nervous system diseases |
| 14 | Aged |
| 7 | Adult |
| 7 | Multiple system atrophy |
| 6 | Multiple System Atrophy (diagnosis) |
| 6 | Parkinsonism |
| 5 | Parkinson disease |
| 5 | Parkinson's disease |
| 4 | Animals |
| 4 | Human |
| 4 | MacLeod syndrome |
| 4 | Multiple System Atrophy (pathology) |
| 4 | Multiple System Atrophy (physiopathology) |
| 4 | Parkinson Disease (complications) |
| 4 | Questionnaires |
| 4 | Sex linked character |
| 4 | multiple system atrophy |
| 3 | Antiparkinson Agents (therapeutic use) |
| 3 | Case study |
| 3 | Diagnosis, Differential |
| 3 | Disease Models, Animal |
| 3 | Electromyography |
| 3 | Magnetic Resonance Imaging |
| 3 | McLeod syndrome |
| 3 | Parkinson Disease (diagnosis) |
| 3 | Reproducibility of Results |
| 3 | Severity of Illness Index |
| 3 | neuroacanthocytosis |
| 2 | Aged, 80 and over |
| 2 | Amino Acid Transport Systems, Neutral (genetics) |
| 2 | Antiparkinson Agents (adverse effects) |
| 2 | Brain (pathology) |
| 2 | Chorea |
| 2 | Chorea (genetics) |
| 2 | Chorea (pathology) |
| 2 | Complication |
| 2 | Corpus Striatum (drug effects) |
| 2 | Corpus Striatum (metabolism) |
| 2 | Corpus Striatum (pathology) |
| 2 | Cross-Sectional Studies |
| 2 | Diagnosis |
| 2 | Diagnostic and Statistical Manual of Mental Disorders |
| 2 | Differential diagnostic |
| 2 | Disability Evaluation |
| 2 | Diseases of the autonomic nervous system |
| 2 | Dopamine (metabolism) |
| 2 | Dystonia |
| 2 | Evaluation scale |
| 2 | Follow-Up Studies |
| 2 | France |
| 2 | France (epidemiology) |
| 2 | Inclusion Bodies (pathology) |
| 2 | Levodopa (adverse effects) |
| 2 | Levodopa (therapeutic use) |
| 2 | Macaca fascicularis |
| 2 | Magnetic Resonance Imaging (methods) |
| 2 | Multiple System Atrophy (genetics) |
| 2 | Multiple System Atrophy (psychology) |
| 2 | Myoclonus |
| 2 | Nerve Tissue Proteins (metabolism) |
| 2 | Neurologic Examination (statistics & numerical data) |
| 2 | Parkinson Disease (epidemiology) |
| 2 | Parkinson Disease (psychology) |
| 2 | Parkinson Disease, Secondary (physiopathology) |
| 2 | Parkinsonian Disorders (drug therapy) |
| 2 | Parkinsonian Disorders (pathology) |
| 2 | Peripheral Nervous System Diseases (complications) |
| 2 | Peripheral Nervous System Diseases (genetics) |
| 2 | Prevalence |
| 2 | Retrospective Studies |
| 2 | chorea |
| 2 | parkinsonism |
| 2 | severity |
| 1 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 1 | 3‐NP |
| 1 | Acanthocytosis |
| 1 | Activities of Daily Living |
| 1 | Activities of Daily Living (classification) |
| 1 | Advisory Committees (standards) |
| 1 | Age Factors |
| 1 | Akathisia, Drug-Induced (physiopathology) |
| 1 | Alcohol Deterrents (adverse effects) |
| 1 | Alcoholism (drug therapy) |
| 1 | Anal Canal (physiopathology) |
| 1 | Anal sphincter |
| 1 | Anal sphincter electromyography |
| 1 | Anemia, Hemolytic (complications) |
| 1 | Anemia, Hemolytic (genetics) |
| 1 | Aneurysm |
| 1 | Animal |
| 1 | Animal model |
| 1 | Antibodies (immunology) |
| 1 | Antiparkinson Agents (administration & dosage) |
| 1 | Antiparkinson Agents (pharmacology) |
| 1 | Ataxia Telangiectasia Mutated Proteins (genetics) |
| 1 | Athlete |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "François Tison"
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i \
-Sk "François Tison" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= France
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= François Tison
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
